Browse > Article

Up-regulation of Heme Oxygenase-1 Expression by cAMP-elevating Agents in RAW 264.7 cells  

Ko, Young-Shin (Department of pharmacology, College of Medicine, Gyeongsang National University, Institute of Health Sciences)
Park, Min-Kyu (Department of pharmacology, College of Medicine, Gyeongsang National University, Institute of Health Sciences)
Kang, Young-Jin (Department of pharmacology, College of Medicine, Gyeongsang National University, Institute of Health Sciences)
Lee, Young-Soo (Department of pharmacology, College of Medicine, Gyeongsang National University, Institute of Health Sciences)
Seo, Han-Geuk (Department of pharmacology, College of Medicine, Gyeongsang National University, Institute of Health Sciences)
Lee, Duck-Hyung (Department of Chemistry, Sogang University)
Yunchoi, Hye-Sook (Natural Products Research Institute, Seoul National University)
Chong, Won-Seog (Department of pharmacology, College of Medicine, Sonam University)
Chang, Ki-Churl (Department of pharmacology, College of Medicine, Gyeongsang National University, Institute of Health Sciences)
Publication Information
Biomolecules & Therapeutics / v.10, no.2, 2002 , pp. 71-77 More about this Journal
Abstract
Heme oxygenase-1 (HO-1) is the inducible from of the rate-limiting enzyme of heme degradation; it regulates the cellular contents of heme. HO-1 is up-regulated by various stimuli including oxidative stress so that it is thought to participate in general cellular defense mechanisms against oxidative stress in mammalian cells. To investigate the role of the cAMP-dependent protein kinase A (PKA) signaling pathway on nitrogen oxidative stress-induced HO-1 gene expression, RAW 264.7 cell cultures were treated with sodium nitroprusside (SNP). SNP increased the expression of HO-1 mRNA and protein, time- and concentration-dependently. Treatment with H89, PKA inhibitor, but not LY83583, guanylate cyclase inhibitor, significantly diminished the HO-1 expression by SNP, indicating that cAMP plays a crucial role in the induction of HO-1. Incubation with cAMP-elevating agents, such as forskolin or isoproterenol resulted in up-regulation of the expression of HO-1. Forskolin-induced expression of HO-1 was inhibited by H89. Furthermore, propranolol, $\beta$-adrenoceptor blocker, inhibited the isoproterenol-induced HO-1 expression, supporting the importance of cAMP in the induction of HO-1 expression. Higenamine-S, but not higenamineR, enhanced the HO-1 expression induced by SNP. Furthermore, cellular toxicity induced by hydrogen peroxide was attenuated by the presence of SNP, which was further increased by the presence of ZnPPIX, HO-1 inhibitor. Collectively, these results strongly suggest that up-regulation of HO-1 expression in RAW 264.7 cells involves PKA signal pathway.
Keywords
Cyclic AMP; heme oxygenase-1; macrophage; oxidative stress;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Abraham, N. G., Lavrovsky, Y., Schwartzman, M. L., Stoltx, R. A., Levere R. D., Gerritsen M. E., Shibahara S. and Kappas A. (1995). Transfection of the human heme oxygenase gene into rabbit coronary microvessel endo-thelial cells: protective effect against home and hemoglobin toxicity. Proc Natl Acad Sci USA., 92, 6798-6802   DOI   ScienceOn
2 Ahmed, A., Rahman, M., Zhang, X., Acevedo, C. H., Nijjar S., Rushton I., Bussolati B. and St John J. (2000). Induction of placental heme oxygenase-1 is protective against TNF-alpha-induced cytotoxicity and promotes vessel relaxation. MoIMed,. 6,391-409
3 Applegate, L. A, Luscher, P, and Tyrrell, R. M. (1991). Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res., 51, 974-978
4 Camhi, S. L., Alam, J., Wiegand, G. W., Chin, B. Y. and Choi, A. M. (1998). Transcriptional activation of the HO-l gene by lipopolysaccharide is mediated by 5' distal enhancers: role of reactive oxygen intermediates and AP-l. Am J Respir Cell Mol. Biol., 18, 226-234   DOI   ScienceOn
5 Chang, K. C., Chong, W. S. and Lee, I. J. (1994). Different pharmacological characteristics of structurally similar benzylisoqumoline analogs, papaverine, higenamine, and GS 389, on isolated rat aorta and heart. Can. J. PhysioI. Pharmacol., 72, 327-3345   DOI   ScienceOn
6 Chang, K. C., Lim, J. K. and Park, C. W. (1986). Synthesis of higenamine and its cardiovascular effects in rabbit:evidence for $\beta$-adrenoceptor agonist. Kor. J. PharmacoI., 22,96-104
7 Chen, K. and Maines, M. D. (2000). Nitric oxide induces heme oxygenase-1 via mitogen-activated protein kinases ERK and P38. Cell. Mol.. Biol., 46, 609-617
8 Christou, H., Morita, T., Hsich, C. M., Koike, H., Arkonac, B., Perrella, M. A. and Kourembanas, S. (2000). Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ Res,. 86, 1224-1229   DOI   ScienceOn
9 Gross, S. S. and Levi, R. (1992). Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J BioI Chem., 25, 267(36):25722-9
10 Immenschuh, S., Kietzmann, T., Hinke, V., Wiederhold, M., Katz, N. and Mullcr-Eberhard, U. (1998). The rat heme oxygenase-1 gene is transcriptionally induced via the protein kinase A signaling pathway in rat hepatocyte cultures. Mol Pharmacol., 53, 483-91   DOI
11 Johnson, R. A, Lavesa, M., Askari, B., Abraham, N. G. and Nasjletti, A. (1995). A heme oxygenase product, Presu-mably carbon monoxide, mediates a vasodepressor role in rats. Hypertension., 25, 166-169   DOI   ScienceOn
12 Johnson, R. A., Lavesa, M., DeSeyn, K., Scholer, M. J. and Nasjletti A. (1996). Heme oxygenase substrates acutely lower blood pressure in hypertensive rats. Am J PhysioI., 271,H1131-H1138   DOI
13 Lee, P. J, Alam, J., Wiegand, G. W. and Choi, A. M. (1996). Overexpression of heme oxygenase-1 in pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proc NatI Acad Sci USA., 93, 10393-10398   DOI   ScienceOn
14 Kang, Y. J., Lee, Y. S., Lee, G. W., Lee, D. H., Ryu, J. C., Yun-Choi, H. S. and Cbang, K. C. (1999). Inhibition of activation of nuclear factor kB is responsible for inhibition of inducible nitric oxide synthase expression by higen-amine, and active component of aconite root. J. Pharmacol. Exp. Ther., 291, 314-320
15 Kyokane, T., Norimizu, S., Taniai, H., Yamaguchi, T., Takeoka, S., Tsuchida, E., Naito, M., Nimura, Y., Ishimura, Y., Suematsu, M. (2001). Carbon monoxide from heme catabolism protects against hepatobiliary dysfunction in endotoxin-treated rat liver. Gastroenterology, 120, 1227-1240   DOI   ScienceOn
16 Lautier, D., Luscher, P. and Tyrrcll, R. M. (1992). Endogenous glutathione levels modulate both constitutive and UVA radiation/oxidant-inducible expression of the human home oxygenase gene- Carcinogenesis., 13, 227-232   DOI   ScienceOn
17 Lee, Y. S., Kang, Y. J., Lee, B. K., Ko, Y. S., Park, M. K., Seo, H.G., Yim-Choi, H. S. and Chang, K. C. (2001). Down-regulation of TNF-a and IL-6 by higenamine is responsible for reduction ofinfarct size and myocardial ischemic injury in the rat. Kor. J. Appl. Pharmacol., 9, 167-175
18 McCoubrey, W. K., Huang, T. J. and Maines, M. D. (1997). Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem., 247, 725-732   DOI   ScienceOn
19 Miano, L. L. J. M., Mercer, B, and Olson, E, N. (1996). Expression of the SM22a promoter in transgenic inice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. JCell Biol., 132, 849-859   DOI   ScienceOn
20 Shibahara, S., Muller, R., Taguchi, H. and Yoshida, T. (1985). Cloning and expression of cDNA for rat heme oxygenase. Proc Natl Acad Sci USA., 82, 7865-7869   DOI   ScienceOn
21 Suematsu, M. and Ishimura, Y. (2000). The heme oxygenase-carbon monoxide system: a regulator of hepatobiliary functions. Hepatology., 31, 3-6   DOI   ScienceOn
22 Trakshel, G. M., Kutty, R. K. and Maines, M. D. (1986). Purification and characterization of the major constitutive form of testicular heme oxygenase. J BioI Chem., 261, 11131-11137
23 Yun-Choi, H. S., Lee, D. H. and Chang, K. C. (2001). Synthesis of optical isomers of tetrahydroisoquinoline compounds and its pharmaceutical composition. Korean Patent Application, 2001-21500